The paper suggests initiating therapy at roughly 1025% of standard starting dose for type 2 diabetes or obesity, which for tirzepatide (approved starting dose 2.5 mg) would be roughly 250625 g, or 0.25 0.625 mg
If youre interested, talk to your healthcare provider about whether you might qualify for a trial near you
The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication
A premature menopause before the age of 40, the difference between Premature Ovarian Insufficiency (POI) and menopause is that for some women the ovaries don't completely shut down so there is a small chance of conception at around 5%
Medications originally created to manage type 2 diabetes are now making headlines for their surprising impact on weight loss
Resistance to high-fat diet-induced obesity but exacerbated insulin resistance in mice overexpressing preadipocyte factor-1 (Pref-1): a new model of partial lipodystrophy
:max_bytes(150000):strip_icc()/Health-GLP1-pill-vs-shot-137cf589ddca421bb0aef5c5d7aec64a.png)
